Literature DB >> 14630932

Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells.

Masaaki Nakayama1, Miyuki Kimura, Akihiro Wada, Kinnosuke Yahiro, Ken-ichi Ogushi, Takuro Niidome, Akihiro Fujikawa, Daisuke Shirasaka, Nobuo Aoyama, Hisao Kurazono, Masaharu Noda, Joel Moss, Toshiya Hirayama.   

Abstract

Persistent Helicobacter pylori colonization in the stomach induces gastritis and peptic ulcer and interferes with ulcer healing. Most strains of H. pylori produce a cytotoxin, VacA, that induces cytoplasmic vacuolation in epithelial cells with structural and functional changes, leading to gastric injury. VacA is known to cause cell death by mitochondrial damage. We hypothesized that VacA might disrupt other signaling pathways; to that end, we examined the effects of VacA on MAPKs to elucidate their role in the abnormalities seen in VacA-treated cells. VacA stimulated phosphorylation of p38 and Erk1/2, but not JNK, in AZ-521 cells. Both phosphorylation and kinase activation of p38 were maximal 10-30 min after addition of VacA and declined thereafter. Treatment with anti-VacA antibody or the p38 inhibitor SB203580 blocked p38 phosphorylation caused by VacA and inhibited VacA-induced phosphorylation of activating transcription factor 2 (ATF-2), which is implicated in transcriptional control of stress-responsive genes. These data indicate that VacA stimulates a p38/ATF-2-mediated signal pathway. However, 10 microM SB203580, which is sufficient to decrease p38 phosphorylation, did not inhibit VacA-induced cellular vacuolation, decrease in mitochondrial membrane potential, or cytochrome c release from mitochondria. These results suggest that VacA-induced activation of p38/ATF-2-mediated signal pathway is independent of cellular vacuolation, decrease in mitochondrial membrane potential, or cytochrome c release from mitochondria caused by VacA. The cytotoxin may thus act independently on several cellular targets, leading to disruption of signaling, regulatory, and metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630932     DOI: 10.1074/jbc.M308898200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells.

Authors:  Ayako Matsumoto; Hajime Isomoto; Masaaki Nakayama; Junzo Hisatsune; Yoshito Nishi; Yujiro Nakashima; Kayoko Matsushima; Hisao Kurazono; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

3.  Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

4.  Involvement of vesicle-associated membrane protein 7 in human gastric epithelial cell vacuolation induced by Helicobacter pylori-produced VacA.

Authors:  Hirosato Mashima; Junko Suzuki; Toshiya Hirayama; Yukako Yoshikumi; Hideki Ohno; Hirohide Ohnishi; Hiroshi Yasuda; Toshiro Fujita; Masao Omata
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

5.  Hemoglobin receptor protein from Porphyromonas gingivalis induces interleukin-8 production in human gingival epithelial cells through stimulation of the mitogen-activated protein kinase and NF-κB signal transduction pathways.

Authors:  Yuki Fujita; Masaaki Nakayama; Mariko Naito; Eiki Yamachika; Tetsuyoshi Inoue; Koji Nakayama; Seiji Iida; Naoya Ohara
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

6.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 7.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

8.  Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin.

Authors:  Holly M Scott Algood; Victor J Torres; Derya Unutmaz; Timothy L Cover
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

9.  Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.

Authors:  Masaaki Nakayama; Junzo Hisatsune; Eiki Yamasaki; Hajime Isomoto; Hisao Kurazono; Masanori Hatakeyama; Takeshi Azuma; Yoshio Yamaoka; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

10.  Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation.

Authors:  Junzo Hisatsune; Masaaki Nakayama; Hajime Isomoto; Hisao Kurazono; Naofumi Mukaida; Asish K Mukhopadhyay; Takeshi Azuma; Yoshio Yamaoka; Jan Sap; Eiki Yamasaki; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.